Title : Disposition and metabolism of LY2603618, a Chk-1 inhibitor following intravenous administration in patients with advanced and/or metastatic solid tumors.

Pub. Date : 2014 Sep

PMID : 24666335






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vitro phenotyping indicated that CYP3A4 was predominantly responsible for the metabolic clearance of LY2603618. LY2603618 cytochrome P450 family 3 subfamily A member 4 Homo sapiens